Efficacy and safety of reduced-dose and slow-infusion intravenous alteplase regimen in patients with acute pulmonary embolism at intermediate-high-risk

Kültürsay, B.Keskin Meriç, BengisuSekban, AhmetHakgör, AykunTokgöz, Hacer CerenTanyeri, S.Kaymaz, Cihangir2025-11-282025-11-282024Kültürsay, B.,Keskin Meriç, B., Sekban, A., Hakgör, A., Tokgöz, H. C., Tanyeri, S. ... Kaymaz, C. (2024). Efficacy and safety of reduced-dose and slow-infusion intravenous alteplase regimen in patients with acute pulmonary embolism at intermediate-high-risk. European Society of Cardiology Congress (ESC), 45. London, England, August 30-September 02, 2024. http://dx.doi.org/10.1093/eurheartj/ehae666.22020195-668X1522-9645http://dx.doi.org/10.1093/eurheartj/ehae666.2202https://hdl.handle.net/20.500.12511/13254...eninfo:eu-repo/semantics/openAccessCardiac & Cardiovascular SystemsCardiologyMeeting AbstractEfficacy and safety of reduced-dose and slow-infusion intravenous alteplase regimen in patients with acute pulmonary embolism at intermediate-high-riskConference Object4510.1093/eurheartj/ehae666.2202Q1WOS:001357019400046